Novo Nordisk and UNICEF Expand Efforts to Tackle Childhood Obesity

Ultragenyx Prices Gene Treatment for Uncommon Diseases At $3.95 Million

Setbacks In Novartis’ Dual Medicine Trials Put Pressure on The Pipeline And CEO

Novartis And Ionis’ Experimental Cardiac Medication Fails to Meet a Crucial Objective in a Widely Monitored Trial

Psychedelic Medication May Be Able to Stop Nerve Damage Brought on by Chemotherapy

Nestle Will Invest $393 Million To Construct a Baby Formula Plant in Brazil